SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,291,994 | +12.6% | 6,090 | +2.2% | 0.95% | +11.9% |
| Q2 2023 | $1,147,254 | -4.4% | 5,961 | +0.5% | 0.85% | +18.9% |
| Q1 2023 | $1,200,445 | +53.7% | 5,929 | -2.4% | 0.72% | +7.2% |
| Q4 2022 | $780,827 | -99.9% | 6,076 | +12.8% | 0.67% | -12.2% |
| Q3 2022 | $737,240,000 | +94417.9% | 5,388 | -0.5% | 0.76% | +53.4% |
| Q1 2022 | $780,000 | -18.2% | 5,413 | -12.3% | 0.50% | -12.1% |
| Q4 2021 | $954,000 | +0.5% | 6,171 | +10.5% | 0.56% | -8.3% |
| Q3 2021 | $949,000 | +14.8% | 5,587 | +6.7% | 0.62% | +35.8% |
| Q2 2021 | $827,000 | +24.0% | 5,238 | +9.1% | 0.45% | +13.8% |
| Q1 2021 | $667,000 | +7.1% | 4,803 | +34.9% | 0.40% | -8.3% |
| Q4 2020 | $623,000 | – | 3,560 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |